Clinical Effectiveness of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Management of Renal Cell Carcinoma: A Single Institution Experience
Tóm tắt
Từ khóa
Tài liệu tham khảo
Jeon, 2010, J Urol, Prognostic value of body mass index in Korean patients with renal cell carcinoma, 448
Schöder, 2004, Semin Nucl Med, Positron emission tomography for prostate, bladder, and renal cancer, 274
Cote, 2012, Cancer Epidemiol Biomarkers Prev, Cigarette smoking and renal cell carcinoma risk among black and white Americans: Effect modification by hypertension and obesity, 770
Scher HI, Motzer RJ. Bladder and renal cell carcinomas. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison′s Principles of Internal Medicine. 16 th ed. New York: McGraw-Hill; 2005. p. 541-3.
Safaei, 2002, Clin Nephrol, The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer, 56
Khandani, 2012, Semin Nucl Med, Positron emission tomography in renal cell carcinoma: An imaging biomarker in development, 221
Liu, 2010, J Urol, Repeat partial nephrectomy on the solitary kidney: Surgical, functional and oncological outcomes, 1719
Press, 1984, AJR Am J Roentgenol, Papillary renal cell carcinoma: CT and sonographic evaluation, 1005
Li, 2012, J Cancer Res Clin Oncol, Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention, 269
Majhail, 2003, J Clin Oncol, F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma, 3995
Fuccio, 2014, Clin Nucl Med, Restaging clear cell renal carcinoma with 18F-FDG PET/CT, e320
Nakatani, 2011, Eur J Radiol, The potential clinical value of FDG-PET for recurrent renal cell carcinoma, 29
Kumar, 2010, Nucl Med Commun, Role of FDG PET-CT in recurrent renal cell carcinoma, 844
Rodríguez, 2010, Rev Esp Med Nucl, Clinical impact of (18) F-FDG PET in management of patients with renal cell carcinoma, 12
Park, 2009, BJU Int, Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma, 615
Dilhuydy, 2006, Oncology, PET scans for decision-making in metastatic renal cell carcinoma: A single-institution evaluation, 339
Jadvar, 2003, Clin Nephrol, Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma, 395
Ramdave, 2001, J Urol, Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma, 825
Fang, 2010, Arch Pathol Lab Med, Intraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp, 1003
Chung, 2012, Urol Oncol, Renal cell carcinoma with metastases to the gallbladder: Four cases from the National Cancer Institute (NCI) and review of the literature, 476
Patard, 2005, J Clin Oncol, Prognostic value of histologic subtypes in renal cell carcinoma: A multicenter experience, 2763
Lee, 2012, BJU Int, Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC), E28
Powles, 2007, Eur Urol, Molecular positron emission tomography and PET/CT imaging in urological malignancies, 1511
Aide, 2003, Eur J Nucl Med Mol Imaging, Efficiency of [(18) F] FDG PET in characterising renal cancer and detecting distant metastases: A comparison with CT, 1236
Kochhar, 2010, J Med Imaging Radiat Oncol, Role of FDG PET/CT in imaging of renal lesions, 347
Schuster, 2004, AJR Am J Roentgenol, Papillary renal cell carcinoma containing fat without calcification mimicking angiomyolipoma on CT, 1402
Seto, 2000, Urology, Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan, 286
Wu, 2002, J Cancer Res Clin Oncol, Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - A preliminary report, 503
Kang, 2004, J Urol, Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma, 1806
Mueller-Lisse, 2010, World J Urol, Imaging of advanced renal cell carcinoma, 253
Garin, 2007, Br J Radiol, CT and MRI in fat-containing papillary renal cell carcinoma, e193
Grant, 2008, J Nucl Med, Skeletal PET with 18F-fluoride: Applying new technology to an old tracer, 68
Lam, 2005, J Urol, Renal cell carcinoma 2005: New frontiers in staging, prognostication and targeted molecular therapy, 1853
